Search
Search
Close this search box.

4 Themes from the Day 1 of MJBizCon 2019‍

Over the course of the past 24 hours, scores of interviews and hundreds of conversations by the Business of Cannabis team, some themes emerged from Day 1 of MJBizCon 2019.

Here are four:

1. Maturation of Industry

The industry is at an inflection point in several key ways. At the show, this has taken the form of a laser-like focus on operations and profitability. Nearly everyone has noted that business fundamentals, rather than wild-eyed speculation will carry companies forward. There has also been a lot of reflection on the size of MJBizCon over the past several years to the types of hyper-specialized vendors (and number of suits) on the floor – the industry is growing up. 

2. US 2019 – A Hemp-Filled Year

The US saw incredible advances in hemp production in 2019 – and the show reflects that. From lawyers to seed purveyors to overall game-planning for the future, hemp was 2019’s MVP in the sector. 

3. The 2020 Outlook

There is a good amount of trepidation permeating the conference. While there is excitement and awareness that the industry is still on a solid path up, the question of ‘who’ will get to the long-term promised land and ‘how’ is causing uncertainty. That, overlayed by an unsettled regulatory (and political) system in the US and a shifting landscape for products and retail in Canada, are making people feel that it’s best to hold on tight for wild 2020.

4. Next MJBizCon

One view that has been expressed over and over again is that by next MJBizCon, a new President of the United States may be elected in the US. A Democrat would significantly alter the course of the US’s cannabis future. (While also saving democracy, the planet and commonsense for the rest of us.)

Follow follow Business of Cannabis on Twitter, LinkedInFacebook and Instagram for the latest from MJBizCon.

– The Business of Cannabis Team

⏰ Pre-order discount ends Jan 15
-- Days
-- Hours
-- Mins
Data packs delivered January 2026
🔬 New Report Due January 2026

Global Medical Cannabis Market Review 2026

A comprehensive analysis of the international medical cannabis supply chain — examining country-specific data on exports, imports, market size, domestic production, and distribution landscapes. Understand the driving forces behind global supply dynamics, the impact of telemedicine on patient access, and regulatory changes shaping the market.

What's covered

  • 📊 Global supply chain overview — understand export/import dynamics and domestic production capabilities
  • 🌍 8 export country snapshots — Canada, Portugal, Denmark, North Macedonia, Spain, Australia, Czech Republic, South Africa
  • 👥 6 patient market snapshots — Australia, Germany, UK, Poland, Brazil, France
  • 🔮 Key themes — Canada's global impact, telemedicine growth, new market openings, quota changes
Export Markets
🇨🇦 Canada 🇵🇹 Portugal 🇩🇰 Denmark 🇲🇰 N. Macedonia 🇪🇸 Spain 🇦🇺 Australia 🇨🇿 Czechia 🇿🇦 South Africa
Patient Markets
🇦🇺 Australia 🇩🇪 Germany 🇬🇧 UK 🇵🇱 Poland 🇧🇷 Brazil 🇫🇷 France
100% free • No credit card required
As trusted by
DIAGEO KPMG Coca-Cola BARCLAYS BNP PARIBAS AB InBev NOVARTIS Johnson & Johnson PEPSICO AXA POLITICO Bloomberg amazon CNN Business
Part of our annual market review series GDPR compliant

Related Posts

Related Posts

CONNECT

Related Posts

Related Posts

Recent Posts

Related Posts

Subscribe to our mailing list to receives daily updates!

We won’t spam you

Categories

Browse by Tags

CATEGORIES

EDITION

BUSINESS OF CANNABIS

© 2023 Prohibition Holdings Ltd. All Rights Reserved.

EDITION

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?